![Wil Honner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wil Honner
Directeur/Membre du Conseil chez Cure Brain Cancer Foundation
Profil
Wil Honner currently works as a Director at the Cure Brain Cancer Foundation.
Postes actifs de Wil Honner
Sociétés | Poste | Début |
---|---|---|
Cure Brain Cancer Foundation
![]() Cure Brain Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Cure Brain Cancer Foundation is a non-profit organization based in Australia that is dedicated to funding innovative brain cancer research. The private company is based in Sydney, Australia. The foundation has invested over $30 million into brain cancer research, including clinical trials and pre-clinical research efforts across pediatric and adult brain cancers. The foundation passionately forges research collaborations, brings world-class clinical trials, and gives people with brain cancer greater access to innovative new treatments. The foundation's mission is to unite the community and rapidly increase brain cancer survival, improving the quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. The Australian company was founded in 2001. Lance Kawaguchi has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Cure Brain Cancer Foundation
![]() Cure Brain Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Cure Brain Cancer Foundation is a non-profit organization based in Australia that is dedicated to funding innovative brain cancer research. The private company is based in Sydney, Australia. The foundation has invested over $30 million into brain cancer research, including clinical trials and pre-clinical research efforts across pediatric and adult brain cancers. The foundation passionately forges research collaborations, brings world-class clinical trials, and gives people with brain cancer greater access to innovative new treatments. The foundation's mission is to unite the community and rapidly increase brain cancer survival, improving the quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. The Australian company was founded in 2001. Lance Kawaguchi has been the CEO of the company since 2021. | Commercial Services |